Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
Active, not recruiting · NCT06447779 · Registry updated 2024-10-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Active, not recruiting | Phase 3 | 2024-10-24 | NCT06447779 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MAXVAX Biotechnology Limited Liability Company | 10 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hebei Provincial Center for Disease Control and Prevention | Shijiazhuang | China | 3 |
| Henan Center for Diseases Control and Prevention | Zhengzhou | China | 3 |
| Hubei Provincial Center for Disease Control and Prevention | Wuhan | China | 2 |
| Yunnan Center For Disease Control and Prevention | Kunming | China | 2 |